Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor-based assays

M Williams1

  • 1Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064-3500.

Current Opinion in Biotechnology
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Recombinant DNA technology aids drug discovery by using cloned receptors for screening. Challenges like receptor patenting and species differences necessitate improved functional assays and diverse ligand sources for effective targeted screening.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

Journal of medicinal chemistry·1996
Same author

Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health.

BMJ (Clinical research ed.)·1996
Same author

The influence of merocyanine 540 and protoporphyrin on physicochemical properties of the erythrocyte membrane.

Biochimica et biophysica acta·1996
Same author

Accelerated fetal lung maturity profiles and maternal cocaine exposure.

Obstetrics and gynecology·1996
Same author

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

The Journal of pharmacology and experimental therapeutics·1996
Same author

Psychopathological syndromes in the functional psychoses: associations with course and outcome.

Psychological medicine·1996
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Pharmacology
  • Biotechnology
  • Drug Discovery

Background:

  • Recombinant DNA technology has advanced targeted screening in drug discovery.
  • Cloned and expressed receptors simplify evaluating novel compounds' structure-activity relationships.

Purpose of the Study:

  • To explore the potential of recombinant DNA technology in drug discovery.
  • To identify limitations and suggest improvements for targeted screening approaches.

Main Methods:

  • Utilizing cloned and expressed receptors as targets.
  • Evaluating novel compounds for structure-affinity/activity.
  • Investigating improved technologies for receptor-ligand interaction measurement.

Main Results:

Related Experiment Videos

  • Cloned receptors simplify structure-affinity/activity assessment.
  • Receptor patenting and species differences pose limitations.
  • Enhanced functional assays and diverse ligand sources are crucial.

    • Conclusions:

    • Recombinant DNA technology enhances targeted drug screening.
    • Overcoming limitations requires strategic focus on ligand sourcing and assay technology.
    • Further development is needed for optimal use of cloned receptors in drug discovery.